查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1950527

週边血管血管造影术导管市场按产品类型、材料、最终用户和应用划分－全球预测，2026-2032年

Peripheral Vascular Angiography Catheter Market by Product Type, Material, End User, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025 年周边血管血管造影术导管市值为 3.7821 亿美元，预计到 2026 年将成长至 3.9886 亿美元，预计到 2032 年将达到 6.1047 亿美元，复合年增长率为 7.07%。

关键市场统计数据
基准年 2025 3.7821亿美元
预计年份：2026年 3.9886亿美元
预测年份 2032 6.1047亿美元
复合年增长率 (%) 7.07%

不断发展的临床实践、器械工程的突破以及采购重点的转变正在重新定义週边血管造影术导管市场。

週边血管造影术导管市场环境正处于介入治疗技术不断进步和器械工程技术不断发展的交汇点，临床医生日益寻求兼具精确性、柔软性和血流动力学安全性的工具。导管设计的创新降低了周边动脉和静脉疾病治疗的手术门槛，同时许多医疗机构正在将手术施行地点转移到门诊和日间诊疗中心。这些趋势，加上临床上对微创技术的日益重视，进一步凸显了兼具诊断清晰度和治疗多功能性的产品系列组合的策略重要性。

临床路径、材料创新和供应链韧性的关键转变正在重塑血管造影术製造商的策略规划

近年来，週边血管造影术导管的竞争格局和临床应用范围发生了多项变革性变化。首先，微创影像引导介入治疗的兴起，推动了对小型化导管的需求，同时要求导管保持管腔完整性和扭矩响应性。其次，先进影像技术和术中引导技术的日益融合，使得导管的渗透性和附件相容性成为关注重点，从而推动了诊断和引导导管系列的设计改进。第三，近期全球范围内的动盪使得供应链韧性成为一项策略重点，促使供应商多元化、策略性库存管理以及与契约製造更紧密的合作成为必然趋势。

分析到2025年，关税和价值链重组带来的成本压力如何推动製造商转向本地化、双重采购和基于价值的筹资策略。

主要经济体关税的征收和贸易政策的变化对采购、成本结构和筹资策略产生了多重影响，到2025年，累积效应将促使业内形成多种应对措施。依赖进口零件和成品的製造商正面临利润率压力，因为不断上涨的到岸成本挑战了他们现有的定价模式。为了应对这项挑战，许多公司正在加快本地化进程以降低风险，转向关键导管组件的双重采购策略，并重新谈判供应商合约以确保价格稳定和可预测的前置作业时间。

以细分市场主导的产品和通路策略：整合设备分类、临床需求、特定应用需求和聚合物材料优势

清晰了解产品、最终用户、应用和材料细分对于确定研发和商业性重点至关重要。基于产品类型的市场结构包括血管成形术导管、诊断导管、引导管、微导管和鞘套导引器器。在引导管产品系列中，Amplats、Judkins 和多用途设计分别满足特定的解剖结构和手术需求，而 Judkins 衍生衍生又进一步细分为左旋和右旋配置，以专门用于适应外周解剖结构的冠状动脉入路技术。每个产品系列都需要独特的性能特征：引导管优先考虑支撑力和扭矩控制，微导管强调在远端和迂曲血管中的操控性，而鞘套导引器需要在止血和易于插入之间取得平衡。

美洲、欧洲、中东和非洲以及亚太地区的区域采用模式、监管差异和采购行为将如何影响製造业和商业优先事项。

区域趋势对商业策略、监管计画和製造地决策有显着影响。在美洲，成熟的医疗程序应用模式与不断增长的门诊介入治疗量以及对综合诊疗路径的重视并存。在美洲，复杂的报销环境和大型医疗系统内部的集中采购模式有利于拥有强有力临床证据和一体化服务产品的供应商。在欧洲、中东和非洲，不同的法规环境和先进影像技术的普及程度差异，使得企业需要采用功能性分层、模组化的产品策略。此外，发展在地化的培训和服务基础设施对于推动产品应用也变得日益重要。在亚太地区，人口结构的变化、中产阶级医疗保健覆盖范围的扩大以及对介入性心臟病学和放射学服务的大力投资，共同为高销量、成本敏感型产品以及与国内製造商合作以应对进口和在地采购趋势创造了有利环境。

成功的医疗设备製造商采用竞争定位和伙伴关係策略，将技术差异化、临床证据和供应链优势结合。

週边血管造影术导管市场竞争格局复杂，由成熟的全球医疗设备公司、专业的导管技术创新者以及专注于特定临床挑战的敏捷型新兴企业组成。大型跨国公司利用其广泛的心血管产品组合，将器材、资本设备和支援服务打包，从而深度整合到医院的采购流程和临床路径中。Start-Ups公司则专注于技术差异化，例如低剖面微导管导航技术、用于增强润滑性和抗血栓性的混合涂层以及可降低库存管理复杂性的模组化鞘套系统。新创公司则专注于突破性功能和行业首创材料，旨在透过有针对性的研究者主导的临床试验以及与主要经销商的策略合作来证明其临床价值。

为製造商提供切实可行的、以行动为导向的建议，以增强供应韧性，建立与临床管道相符的产品系列，并透过证据和培训加速临床医生采用。

为了将洞察转化为可衡量的策略行动，产业领导者应优先考虑能够平衡短期韧性和长期创新的可行事项。首先，优先考虑供应商多元化和区域製造地扩张，以保持利润率柔软性，同时降低关税和物流风险。其次，透过提供模组化套件和整合SKU，根据不同机构（如门诊手术中心、心臟专科中心、诊断中心或医院）的细微需求客製化产品组合，从而简化采购和库存管理。第三，投资产生产品系列数据，以证实医疗设备在周边动脉和静脉手术的表现，尤其要重视能够直接吸引采购委员会和支付者的真实世界註册研究和卫生经济学分析。

严谨的多学科研究途径，结合专家访谈、临床文献综合分析、监管和专利分析以及供应链图谱分析，确保了研究结果的可靠性和可操作性。

本分析所依据的研究结合了结构化的初步研究（包括与领域专家的访谈）和临床文献、监管文件、器械註册资料和专利概况的二次研究。初步研究包括对介入医师、采购人员和监管顾问进行定性访谈，以了解实际应用中器械的性能预期、采购行为和临床工作流程的限制。二次研究整合了关于週边血管介入的同行评审研究文章、政府器械註册文件和专业学会的程序指南，以检验关于临床趋势和材料性能的论点。

从策略层面整合了决定週边血管血管造影术导管生态系统竞争优势的关键临床、商业性和供应链问题。

週边血管造影术导管领域正处于一个转折点：临床对微创、高性能器械的需求不断增长，而商业性和监管的复杂性也日益增加。导管设计和材料的技术进步使得周边介入治疗更加精准、风险更低，而采购趋势和区域动态的变化则迫使製造商必须兼顾适应性和策略性。关税相关的成本压力凸显了在地化生产和采购多元化的必要性，而门诊和专科护理中心的兴起正在重塑产品需求和市场推广策略。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 週边血管血管造影术导管市场（依产品类型划分）

  • 血管成形术导管
  • 诊断导管
  • 引导管
    • Amplatz导管
    • 朱德金斯导管
    • 多用途导管
  • 微导管
  • 鞘套导引器

9. 週边血管血管造影术导管市场（依材料划分）

  • 聚氨酯
  • PVC
  • 硅酮

10. 依最终用户分類的周边血管血管造影术导管市场

  • 门诊手术中心
  • 心臟中心
  • 诊断中心
  • 医院

第十一章 依应用分類的周边血管血管造影术导管市场

  • 週边动脉
  • 週边静脉

12. 週边血管血管造影术导管市场（依地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 週边血管血管造影术导管市场（依类别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

14. 各国週边血管血管造影术导管市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

15. 美国週边血管血管造影术导管市场

第十六章 中国週边血管血管造影术导管市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Acandis GmbH & Co. KG
  • AngioDynamics, Inc.
  • Asahi Intecc Co., Ltd.
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cardiva Corporation
  • Cook Group Incorporated
  • Cordis Corporation
  • GE Healthcare
  • iVascular SLU
  • Koninklijke Philips NV
  • Lepu Medical Technology Co., Ltd.
  • Medikit Co., Ltd.
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • MicroPort Scientific Corporation
  • Nipro Corporation
  • Oscor, Inc.
  • Penumbra, Inc.
  • Siemens Healthineers
  • Teleflex Incorporated
  • Terumo Corporation
Product Code: MRR-4F7A6D4FD8BE

The Peripheral Vascular Angiography Catheter Market was valued at USD 378.21 million in 2025 and is projected to grow to USD 398.86 million in 2026, with a CAGR of 7.07%, reaching USD 610.47 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 378.21 million
Estimated Year [2026] USD 398.86 million
Forecast Year [2032] USD 610.47 million
CAGR (%) 7.07%

How evolving clinical practice, device engineering breakthroughs, and shifting procurement priorities are redefining the peripheral vascular angiography catheter landscape

The peripheral vascular angiography catheter landscape sits at the intersection of advancing interventional practice and evolving device engineering, where clinicians increasingly demand tools that deliver precision, flexibility, and hemodynamic safety. Innovations in catheter design have lowered procedural thresholds for treating peripheral artery and venous disease, while procedural pathways have shifted toward ambulatory and outpatient settings in many health systems. These trends, coupled with growing clinical emphasis on minimally invasive techniques, have elevated the strategic importance of product portfolios that offer both diagnostic clarity and therapeutic versatility.

Underlying this transition is a more complex supply chain and a heightened expectation for clinical evidence. Health systems and specialty centers are asking for devices that not only demonstrate technical performance in tortuous anatomy but also integrate seamlessly into existing procedural workflows. As a result, manufacturers are prioritizing improvements in deliverability, lubricity, radiopacity, and kink resistance while also investing in training programs, procedural support services, and partnerships with clinicians to accelerate adoption. This introduction frames the subsequent analysis by situating product innovation, procurement pressures, and clinical practice evolution as the primary forces shaping strategy and investment decisions in the vascular catheter arena.

Major shifts in clinical pathways, materials innovation, and supply chain resilience that are reshaping strategic planning for vascular angiography catheter manufacturers

Over recent years, several transformative shifts have altered the competitive and clinical terrain for peripheral vascular angiography catheters. First, procedural migration toward less invasive, image-guided interventions has increased demand for smaller-profile devices that maintain lumen integrity and torque response. Second, the integration of advanced imaging modalities and intraprocedural guidance has placed a premium on catheter radiopacity and accessory compatibility, prompting design refinements across diagnostic and guiding families. Third, supply chain resilience has become a strategic priority after recent global disruptions, encouraging a reassessment of supplier diversification, strategic stocking, and closer collaboration with contract manufacturers.

Simultaneously, materials science progress-particularly enhancements in polyurethane formulations and silicone coatings-has improved catheter longevity, biocompatibility, and patient comfort, while polymer selection increasingly differentiates product offerings. Clinical practice patterns have also shifted; more complex peripheral interventions now occur in ambulatory surgical centers and specialty clinics, which has led companies to develop bundled procedural solutions and simplified inventory footprints. These shifts are accompanied by a growing regulatory focus on post-market surveillance and real-world evidence, which together are nudging manufacturers to align product development with robust clinical validation and lifecycle data collection strategies.

Analyzing how tariff-driven cost pressures and supply chain realignments through 2025 have pushed manufacturers toward localization, dual-sourcing, and value-based procurement strategies

The introduction of tariffs or trade policy changes in a major economy can produce layered effects across procurement, cost structures, and sourcing strategies, and the cumulative impact through 2025 has crystallized several industry responses. Manufacturers dependent on imported components or finished devices have faced higher landed costs that challenge existing pricing models and compress margins. In response, many firms accelerated localization efforts to mitigate exposure, moved to dual-sourcing strategies for critical catheter components, and renegotiated supplier agreements to secure price stability and predictable lead times.

Procurement organizations in hospitals and specialty centers have translated increased unit costs into stricter tender evaluation and longer purchasing cycles, with an emphasis on total cost of ownership rather than unit price alone. For device makers, this has translated into more active engagement with group purchasing organizations, heightened focus on value propositions tied to procedural efficiency and complication reduction, and the exploration of financing constructs that smooth capital outlays for buyers. The cumulative regulatory and tariff-driven friction has also amplified the appeal of vertically integrated manufacturing models and regional production footprints that can insulate revenues from future trade disruptions. Collectively, these dynamics have accelerated strategic moves toward supply chain transparency, inventory optimization, and closer commercial alignment with high-volume clinical sites that can underwrite price negotiation flexibility.

Segment-driven product and channel strategies that integrate device typology, clinical setting requirements, application-specific needs, and polymer material advantages

A clear understanding of product, end-user, application, and material segmentation is essential to prioritize R&D and commercial focus. Based on product type, the landscape encompasses angioplasty catheter, diagnostic catheter, guiding catheter, microcatheter, and sheath introducer lines; within guiding catheter offerings, Amplatz, Judkins, and multipurpose designs address specific anatomic and procedural needs, and Judkins variants further bifurcate into left and right configurations tailored for coronary access approaches adapted to peripheral anatomy. Each product family demands unique performance attributes-guiding catheters prioritize backup support and torque control, microcatheters emphasize navigability in distal, tortuous vessels, and sheath introducers balance hemostasis with ease of insertion.

Considering end-user segmentation, devices are deployed across ambulatory surgical centers, cardiac specialty centers, diagnostic centers, and hospitals, and these channels differ substantially in procurement cadence, inventory tolerance, and clinical throughput. Ambulatory and specialty centers often prioritize compact, multipurpose kits that reduce turnover time and inventory complexity, whereas hospitals and diagnostic centers may require a broader range of catheter sizes and designs to accommodate higher procedural complexity. Application-focused differentiation between peripheral artery and peripheral vein interventions further influences device specification and ancillary tooling; arterial work typically demands higher support and trackability, while venous interventions emphasize flexibility and thrombus management capabilities. Material segmentation-polyurethane, PVC, and silicone-creates another axis of differentiation: polyurethane is frequently selected for a balance of strength and flexibility, PVC for cost-effective disposable implements, and silicone for improved biocompatibility and patient comfort in long-dwell or tunneled contexts. Integrating these segmentation dimensions into portfolio decisions enables companies to align product development investments with the clinical realities and procurement behaviors of their highest-value channels.

How regional adoption patterns, regulatory diversity, and procurement behavior across the Americas, Europe Middle East & Africa, and Asia-Pacific should influence manufacturing and commercial priorities

Regional dynamics exert a powerful influence on commercial strategy, regulatory planning, and manufacturing footprint decisions. In the Americas, mature procedural adoption patterns coexist with increasing outpatient intervention volume and an emphasis on bundled care pathways; here, reimbursement environment complexity and centralized purchasing at large health systems can favor suppliers with strong clinical evidence and integrated service offerings. In Europe, Middle East & Africa, heterogeneous regulatory environments and variable access to advanced imaging mean that product strategies must be more modular, with tiers of feature sets and a greater need for localized training and service infrastructure to accelerate adoption. In the Asia-Pacific region, demographic shifts, expanding middle-class access to care, and strong investment in interventional cardiology and radiology services create a fertile environment for higher-volume, cost-sensitive offerings and for partnerships with domestic manufacturers to navigate import dynamics and local procurement preferences.

Each region also presents distinct supply chain considerations: short lead times and localized stocking models in the Americas, regulatory harmonization efforts and multi-country distributor networks in Europe, Middle East & Africa, and rapid scale-up requirements paired with price sensitivity in Asia-Pacific. These regional contrasts should guide where to situate manufacturing capacity, how to structure commercial teams, and which clinical evidence packages to prioritize for regulatory submissions and payer dialogues.

Competitive positioning and partnership strategies that successful device makers use to combine technical differentiation, clinical evidence, and supply chain advantage

Competitive dynamics in the peripheral vascular angiography catheter sector are shaped by a mix of established global medtech firms, specialized catheter innovators, and nimble start-ups focused on niche clinical problems. Leading multinational companies leverage broad cardiovascular portfolios to bundle devices, capital equipment, and support services, which enables deep integration into hospital purchasing cycles and clinical pathways. Specialized firms concentrate on technical differentiation such as low-profile microcatheter navigation, hybrid coatings to enhance lubricity and thrombogenic resistance, or modular sheath systems that reduce inventory complexity. Start-ups often focus on disruptive features or first-in-class materials, aiming to demonstrate clinical value through targeted investigator-led studies and strategic partnerships with larger distributors.

Across these company types, common strategic imperatives emerge: invest in clinical evidence generation to support hospital adoption, optimize supply chains to reduce lead times and cost volatility, and build training and procedural support models that lower the operational friction for clinicians. Mergers and acquisitions continue to be a lever for scale and portfolio breadth, and strategic partnerships with contract manufacturers or regional distributors help address local market access challenges. Ultimately, companies that couple robust technical performance with clear economic value propositions and comprehensive clinician support are best placed to win long-term adoption in high-volume procedural settings.

Practical, execution-focused recommendations for manufacturers to strengthen supply resilience, tailor portfolios to clinical channels, and accelerate clinician adoption with evidence and training

To convert insights into measurable strategic moves, industry leaders should pursue a set of actionable priorities that balance near-term resilience with long-term innovation. First, prioritize supplier diversification and regional manufacturing footprints to mitigate tariff and logistics risks while preserving margin flexibility. Second, align product portfolios to the nuanced needs of ambulatory surgical centers, cardiac specialty centers, diagnostic centers, and hospitals by offering modular kits and consolidated SKUs that simplify purchasing and inventory management. Third, invest in clinical data generation that demonstrates device performance in peripheral artery and venous procedures-emphasize real-world registries and health economic analyses that speak directly to procurement committees and payers.

In parallel, refine material strategies by validating polyurethane, PVC, and silicone options across clinical scenarios to optimize performance, cost, and biocompatibility. Strengthen clinician training and procedural support through simulation, proctoring, and digital resources to accelerate adoption of newer guiding, microcatheter, and sheath introducer technologies. Finally, pursue commercial models that foreground total cost of care reductions, such as bundled pricing or outcome-tied contracts, and build partnerships with high-volume clinical sites to pilot innovative offerings before broader rollout. These recommendations, taken together, will improve resilience to policy shifts, enhance uptake in diverse clinical channels, and sharpen the value narrative for procurement decision-makers.

A rigorous blended research approach combining expert interviews, clinical literature synthesis, regulatory and patent analysis, and supply chain mapping to ensure robust, actionable insights

The research underpinning this analysis combined structured primary engagement with domain experts and targeted secondary investigation across clinical literature, regulatory filings, device registries, and patent landscapes. Primary research included qualitative interviews with interventionalists, procurement leaders, and regulatory consultants to surface real-world device performance expectations, procurement behaviors, and clinical workflow constraints. Secondary efforts synthesized peer-reviewed studies on peripheral interventions, governmental device registration documents, and procedural guidance from professional societies to validate clinical trends and material performance claims.

Supplementing these sources, supply chain mapping and vendor capability assessments were conducted to identify concentration risks, lead-time sensitivities, and redundancies in critical component sourcing. Competitive positioning analysis drew on publicly available product documentation, patent filings, and clinical trial registries to evaluate differentiation and pipeline activity. Throughout, findings were triangulated to ensure consistency between clinical practice patterns, procurement signals, and product feature sets, producing a defensible and actionable body of insights for strategic decision-making.

Strategic synthesis of clinical, commercial, and supply chain imperatives that will determine competitive winners in the peripheral vascular angiography catheter ecosystem

The peripheral vascular angiography catheter sector is at an inflection point where clinical demand for minimally invasive, high-performance devices meets heightened commercial and regulatory complexity. Technological advances in catheter design and materials are enabling more precise, lower-risk peripheral interventions, while shifting procurement and regional dynamics require manufacturers to be both adaptable and strategic. Tariff-related cost pressures have underscored the need for localized manufacturing and diversified sourcing, and the rise of ambulatory and specialty care settings has reshaped product requirements and go-to-market approaches.

For decision-makers, the path forward is clear: align product development with the differentiated needs of specific clinical channels and applications, invest in robust clinical evidence and clinician support programs, and shore up supply chain resilience to protect margins and ensure continuity of supply. Companies that successfully integrate these elements will be better positioned to win preference among clinicians and procurement leaders and to sustain adoption as procedural volumes continue to migrate to less invasive care settings.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Peripheral Vascular Angiography Catheter Market, by Product Type

  • 8.1. Angioplasty Catheter
  • 8.2. Diagnostic Catheter
  • 8.3. Guiding Catheter
    • 8.3.1. Amplatz Catheter
    • 8.3.2. Judkins Catheter
    • 8.3.3. Multipurpose Catheter
  • 8.4. Microcatheter
  • 8.5. Sheath Introducer

9. Peripheral Vascular Angiography Catheter Market, by Material

  • 9.1. Polyurethane
  • 9.2. PVC
  • 9.3. Silicone

10. Peripheral Vascular Angiography Catheter Market, by End User

  • 10.1. Ambulatory Surgical Center
  • 10.2. Cardiac Specialty Center
  • 10.3. Diagnostic Center
  • 10.4. Hospitals

11. Peripheral Vascular Angiography Catheter Market, by Application

  • 11.1. Peripheral Artery
  • 11.2. Peripheral Vein

12. Peripheral Vascular Angiography Catheter Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Peripheral Vascular Angiography Catheter Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Peripheral Vascular Angiography Catheter Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Peripheral Vascular Angiography Catheter Market

16. China Peripheral Vascular Angiography Catheter Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Acandis GmbH & Co. KG
  • 17.6. AngioDynamics, Inc.
  • 17.7. Asahi Intecc Co., Ltd.
  • 17.8. B. Braun Melsungen AG
  • 17.9. Becton, Dickinson and Company
  • 17.10. Biotronik SE & Co. KG
  • 17.11. Boston Scientific Corporation
  • 17.12. Cardiva Corporation
  • 17.13. Cook Group Incorporated
  • 17.14. Cordis Corporation
  • 17.15. GE Healthcare
  • 17.16. iVascular S.L.U.
  • 17.17. Koninklijke Philips N.V.
  • 17.18. Lepu Medical Technology Co., Ltd.
  • 17.19. Medikit Co., Ltd.
  • 17.20. Medtronic plc
  • 17.21. Merit Medical Systems, Inc.
  • 17.22. MicroPort Scientific Corporation
  • 17.23. Nipro Corporation
  • 17.24. Oscor, Inc.
  • 17.25. Penumbra, Inc.
  • 17.26. Siemens Healthineers
  • 17.27. Teleflex Incorporated
  • 17.28. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY ANGIOPLASTY CATHETER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY ANGIOPLASTY CATHETER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY ANGIOPLASTY CATHETER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY DIAGNOSTIC CATHETER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY DIAGNOSTIC CATHETER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY DIAGNOSTIC CATHETER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY GUIDING CATHETER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY GUIDING CATHETER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY GUIDING CATHETER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY GUIDING CATHETER, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY AMPLATZ CATHETER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY AMPLATZ CATHETER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY AMPLATZ CATHETER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY JUDKINS CATHETER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY JUDKINS CATHETER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY JUDKINS CATHETER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY MULTIPURPOSE CATHETER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY MULTIPURPOSE CATHETER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY MULTIPURPOSE CATHETER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY MICROCATHETER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY MICROCATHETER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY MICROCATHETER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY SHEATH INTRODUCER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY SHEATH INTRODUCER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY SHEATH INTRODUCER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY POLYURETHANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY POLYURETHANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY POLYURETHANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY PVC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY PVC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY PVC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY SILICONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY SILICONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY SILICONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY CARDIAC SPECIALTY CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY CARDIAC SPECIALTY CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY CARDIAC SPECIALTY CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY DIAGNOSTIC CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY DIAGNOSTIC CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY DIAGNOSTIC CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY PERIPHERAL ARTERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY PERIPHERAL ARTERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY PERIPHERAL ARTERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY PERIPHERAL VEIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY PERIPHERAL VEIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY PERIPHERAL VEIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. AMERICAS PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 60. AMERICAS PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 61. AMERICAS PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY GUIDING CATHETER, 2018-2032 (USD MILLION)
  • TABLE 62. AMERICAS PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 65. NORTH AMERICA PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. NORTH AMERICA PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY GUIDING CATHETER, 2018-2032 (USD MILLION)
  • TABLE 68. NORTH AMERICA PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 69. NORTH AMERICA PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 71. LATIN AMERICA PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. LATIN AMERICA PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 73. LATIN AMERICA PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY GUIDING CATHETER, 2018-2032 (USD MILLION)
  • TABLE 74. LATIN AMERICA PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 75. LATIN AMERICA PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 76. LATIN AMERICA PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY GUIDING CATHETER, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY GUIDING CATHETER, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 89. MIDDLE EAST PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. MIDDLE EAST PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. MIDDLE EAST PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY GUIDING CATHETER, 2018-2032 (USD MILLION)
  • TABLE 92. MIDDLE EAST PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 93. MIDDLE EAST PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 94. MIDDLE EAST PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 95. AFRICA PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. AFRICA PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. AFRICA PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY GUIDING CATHETER, 2018-2032 (USD MILLION)
  • TABLE 98. AFRICA PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 99. AFRICA PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 100. AFRICA PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY GUIDING CATHETER, 2018-2032 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. ASEAN PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. ASEAN PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. ASEAN PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY GUIDING CATHETER, 2018-2032 (USD MILLION)
  • TABLE 111. ASEAN PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 112. ASEAN PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 113. ASEAN PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. GCC PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GCC PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. GCC PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY GUIDING CATHETER, 2018-2032 (USD MILLION)
  • TABLE 117. GCC PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 118. GCC PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. GCC PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPEAN UNION PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPEAN UNION PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPEAN UNION PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY GUIDING CATHETER, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPEAN UNION PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPEAN UNION PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPEAN UNION PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. BRICS PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. BRICS PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. BRICS PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY GUIDING CATHETER, 2018-2032 (USD MILLION)
  • TABLE 129. BRICS PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 130. BRICS PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. BRICS PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 132. G7 PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. G7 PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. G7 PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY GUIDING CATHETER, 2018-2032 (USD MILLION)
  • TABLE 135. G7 PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 136. G7 PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 137. G7 PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 138. NATO PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. NATO PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. NATO PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY GUIDING CATHETER, 2018-2032 (USD MILLION)
  • TABLE 141. NATO PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 142. NATO PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. NATO PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. UNITED STATES PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 146. UNITED STATES PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. UNITED STATES PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY GUIDING CATHETER, 2018-2032 (USD MILLION)
  • TABLE 148. UNITED STATES PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 149. UNITED STATES PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 150. UNITED STATES PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. CHINA PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 152. CHINA PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. CHINA PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY GUIDING CATHETER, 2018-2032 (USD MILLION)
  • TABLE 154. CHINA PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 155. CHINA PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. CHINA PERIPHERAL VASCULAR ANGIOGRAPHY CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)